Bristol-Myers Squibb is a global biopharmaceutical company dedicated to helping patients prevail against serious diseases, such as cancer, HIV/AIDS, psychiatric disorders, rheumatoid arthritis, hepatitis B, diabetes or heart disease.

Our company constantly looks into the future. We consistently use the latest biotechnological solutions and extensive experience and resources of our company. This approach makes us a new generation company – leader in the biopharmaceutical market. Since 2002, we have introduced eight new drugs. A number of new products responding to the unmet medical needs are in the final stage of clinical trials.

In 2008, the clinical trials organised and monitored by the Company focused on five main disease areas: oncology, virology, psychiatry, immunology and metabolic diseases. What stands BMS apart is the fact that we have located our clinical trials centre for the European region, covering Poland, Russia, Czech Republic, Hungary, Romania, Turkey and Ukraine, in Poland. Trials conducted in this region account for 18 per cent of all trials carried out by the company.

Bristol-Myers Company was founded in 1887 in the United States by two young entrepreneurs: William McLaren Bristol and John Ripley Myers. Squibb Corporation was set up in 1858. Its founder was Dr Edward Robinson Squibb. For over a century both firms developed and grew, merging in 1989 to create Bristol-Myers Squibb. Today, Bristol-Myers Squibb is a leading biopharmaceutical company committed to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. In the year 2009, the total sales of the firm world-wide reached over USD 18 billion.

Bristol-Myers Squibb in Poland

Squibb Corporation opened its office in Poland in 1968, and Bristol-Myers in 1970. In 1995, our office was transformed into a limited liability company. Since 2002, we have been operating in Poland as Bristol-Myers Squibb Polska Sp. z o.o. and Bristol-Myers Squibb Services Sp. z o.o. The object of BMS Polska is sales, marketing, import, export and distribution of medicines. The activities of BMS Services involve organising and supervising clinical trials and providing promotional services for our products.